Lymph Node Fine-Needle Cytology: Beyond Flow Cytometry

Autor: Pio Zeppa, Anna Lucia Peluso, Antonio Ieni, Chiara Mignogna
Rok vydání: 2016
Předmět:
0301 basic medicine
Lymphoma
Biopsy
Translocation
Genetic

law.invention
0302 clinical medicine
Immunophenotyping
law
Diagnosis
In Situ Hybridization
Fluorescence

In Situ Hybridization
Polymerase chain reaction
Sanger sequencing
Comparative Genomic Hybridization
medicine.diagnostic_test
Lymphoma
Non-Hodgkin

General Medicine
Flow Cytometry
030220 oncology & carcinogenesis
symbols
Histology
Cytodiagnosis
Biopsy
Fine-Needle

IGH/T-cell receptor clonality tests
Non-Hodgkin
Translocation
Chromogenic in situ hybridization
Fluorescence
DNA sequencing
Pathology and Forensic Medicine
Diagnosis
Differential

Lymph node cytology
03 medical and health sciences
symbols.namesake
Genetic
medicine
Humans
Fine-needle cytology
Flow cytometry
High-Throughput technologies
Next-generation sequencing
Lymph Nodes
business.industry
High-throughput technologies
2734
Molecular biology
Gene expression profiling
030104 developmental biology
Differential
Fine-Needle
business
Fluorescence in situ hybridization
Comparative genomic hybridization
Zdroj: Acta Cytologica. 60:372-384
ISSN: 1938-2650
0001-5547
DOI: 10.1159/000447734
Popis: Lymph node (LN) fine-needle cytology (FNC) coupled with flow cytometry immunophenotyping provides relevant information for the diagnosis of non-Hodgkin lymphoma (NHL). Numerous studies have shown FNC samples to be suitable for different molecular procedures; in this review, some of the molecular procedures most commonly employed for NHL are briefly described and evaluated in this perspective. Fluorescence in situ hybridization and chromogenic in situ hybridization are briefly described. Polymerase chain reaction (PCR)-based assays are used to identify and quantify mutations and translocations, namely immunoglobulin (IGH) and T-cell receptor rearrangements by clonality testing and IGVH somatic hypermutations either by Sanger sequencing, single-strand conformational polymorphisms or RT-PCR strategies. High-throughput technologies (HTT) encompass numerous and different diagnostic tools that share the capacity of multiple molecular investigation and sample processing in a fast and reproducible manner. HTT includes gene expression profiling, comparative genomic hybridization, single-nucleotide polymorphism arrays and next-generation sequencing technologies. A brief description of these tools and their potential application to LN FNC is reported. The challenge for FNC will be to achieve new knowledge and apply new technologies to FNC, exploiting its own basic qualities.
Databáze: OpenAIRE